George Hunnewell is an accomplished healthcare executive with a diverse professional background. He studied engineering sciences at Harvard University and went on to earn an MBA from the Massachusetts Institute of Technology - Sloan School of Management. Hunnewell has held numerous leadership positions within the healthcare industry, including serving as Chief Operating Officer and President of Clinical Trials at Cogstate and Corporate Vice President of Clinical Operations at PAREXEL International. He has also held executive roles in corporate and business development at various companies, including QuantiaMD and PAREXEL Informatics. Most recently, Hunnewell has served as CEO of RxMx and as an executive in residence at both SV Health Investors and Silversmith Capital Partners. Hunnewell's broad experience and expertise have made him a sought-after industry leader in healthcare and business.